Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells

Journal of Hematology and Oncology

Volumn 1, Issue 1, 2008, Pages

  Lim, Che K ^a   Sun, Li ^a   Feng, Qi ^a,e   Law, Ping ^b   Chua, Wei T ^c   Lim, Shy N ^c   Hwang, William Y K ^a,d,e  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b StemCyte   (United States)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e Singapore Cord Blood Bank   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CANCER ANTIBODY; CD34 ANTIGEN; CD52 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ARTICLE; BONE MARROW CELL; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CLONOGENIC ASSAY; CULTURE TECHNIQUE; CYTOLOGY; FETUS BLOOD; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; LYMPHOCYTE; MEGAKARYOCYTE; METHODOLOGY;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, NEOPLASM; CELL COUNT; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; FETAL BLOOD; GLYCOPROTEINS; HEMATOPOIETIC STEM CELLS; LYMPHOCYTES; MEGAKARYOCYTES; MYELOID CELLS;

EID: 77953032292     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-1-19     Document Type: Article

References (40)

1. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P, et al.: Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989, 321(17):1174-1178. (Pubitemid 19255814)
2. Rocha V, Sanz G, Gluckman E: Umbilical cord blood transplantation. Curr Opin Hematol 2004, 11(6):375-385. (Pubitemid 39491430)
3. Hwang WY, Samuel M, Tan D, Koh LP, Lim W, Linn YC: A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol Blood Marrow Transplant 2007, 13(4):444-453. (Pubitemid 46421885)
4. Ballen KK, Haley NR, Kurtzberg J, Lane TA, Lindgren BR, Miller JP, Newman B, McCullough J: Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank. Transfusion 2006, 46(12):2063-2070. (Pubitemid 44813723)
5. Grewal SS, Barker JN, Davies SM, Wagner JE: Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003, 101(11):4233-4244. (Pubitemid 36857783)
6. Huang S, Law P, Young D, Ho AD: Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood. Exp Hematol 1998, 26(12):1162-1171. (Pubitemid 28507292)
7. Klaus J, Herrmann D, Breitkreutz I, Hegenbart U, Mazitschek U, Egerer G, Cremer FW, Lowenthal RM, Huesing J, Fruehauf S, Moehler T, Ho AD, Goldschmidt H: Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Eur J Haematol 2007, 78(1):21-28. (Pubitemid 46018554)
8. Martin PL, Carter SL, Kernan NA, Sahdev I, Wall D, Pietryga D, Wagner JE, Kurtzberg J: Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 2006, 12(2):184-194. (Pubitemid 43138013)
9. Barker JN, Weisdorf DJ, Wagner JE: Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001, 344(24):1870-1871. (Pubitemid 32538709)
10. De Lima M, St John LS, Wieder ED, Lee MS, McMannis J, Karandish S, Giralt S, Beran M, Couriel D, Korbling M, Bibawi S, Champlin R, Komanduri KV: Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. Br J Haematol 2002, 119(3):773-776. (Pubitemid 35366222)
11. Ruggeri A, Peffault de Latour R, Rocha V, Larghero J, Robin M, Rodrigues CA, Traineau R, Ribaud P, Ferry C, Devergie A, Gluckman E, Socié G: Double cord blood transplantation in patients with high risk bone marrow failure syndromes. Br J Haematol 2008.
12. Zhang L, Shen B, Hou H, Yan W, Dai Y, Shi Q, Ma X, Ju X, Liu X: [Effects of HLA disparity of two umbilical cord blood units on human engraftment in SCID mice]. Zhonghua Xue Ye Xue Za Zhi 2002, 23(12):624-627.
13. Haylock DN, Nilsson SK: Expansion of umbilical cord blood for clinical transplantation. Curr Stem Cell Res Ther 2007, 2(4):324-335.
14. Hofmeister CC, Zhang J, Knight KL, Le P, Stiff PJ: Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant 2007, 39(1):11-23. (Pubitemid 44921650)
15. Robinson S, Niu T, de Lima M, Ng J, Yang H, McMannis J, Karandish S, Sadeghi T, Fu P, del Angel M, O'Connor S, Champlin R, Shpall E: Ex vivo expansion of umbilical cord blood. Cytotherapy 2005, 7(3):243-250. (Pubitemid 41051366)
16. Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin PL, Driscoll TA, Howrey R, Chao N, Douville J, Burhop S, Fu P, Kurtzberg J: Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 2003, 101(12):5061-5067. (Pubitemid 36857774)
17. Koller MR, Manchel I, Maher RJ, Goltry KL, Armstrong RD, Smith AK: Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system. Bone Marrow Transplant 1998, 21(7):653-663. (Pubitemid 28159601)
18. Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, Bearman SI, Nieto Y, Freed B, Madinger N, Hogan CJ, Slat-Vasquez V, Russell P, Blunk B, Schissel D, Hild E, Malcolm J, Ward W, McNiece IK: Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002, 8(7):368-376.
19. Stiff P, Chen B, Franklin W, Oldenberg D, Hsi E, Bayer R, Shpall E, Douville J, Mandalam R, Malhotra D, Muller T, Armstrong RD, Smith A: Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood 2000, 95(6):2169-2174. (Pubitemid 30151662)
20. Christopherson KW 2nd, Uralil SE, Porecha NK, Zabriskie RC, Kidd SM, Ramin SM: G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38-human cord blood hematopoietic cells. Exp Hematol 2006, 34(8):1060-1068. (Pubitemid 44080377)
21. Hutton JF, D'Andrea RJ, Lewis ID: Potential for clinical ex vivo expansion of cord blood haemopoietic stem cells using non-haemopoietic factor supplements. Curr Stem Cell Res Ther 2007, 2(3):229-237. (Pubitemid 47496607)
22. Deutsch VR, Nagler A, Slavin S, Condiotti R, Levine RF, Eldor A: Effect of bone marrow T lymphocytes treated with CAM-PATH 1 G on megakaryocyte colony formation. Exp Hematol 1993, 21(11):1427-1435. (Pubitemid 24215363)
23. Hale G: Cd52 (Campath1). J Biol Regul Homeost Agents 2001, 15(4):386-391.
24. Hale G, Bright S, Chumbley G, Hoang T, Metcalf D, Munro AJ, Waldmann H: Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood 1983, 62(4):873-882. (Pubitemid 13008678)
25. Ravandi F, O'Brien S: Alemtuzumab. Expert Rev Anticancer Ther 2005, 5(1):39-51. (Pubitemid 40287435)
26. Rowan WC, Hale G, Tite JP, Brett SJ: Cross-linking of the CAM-PATH-1 antigen (CD52) triggers activation of normal human T lymphocytes. Int Immunol 1995, 7(1):69-77.
27. Xia MQ, Hale G, Waldmann H: Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigen. Mol Immunol 1993, 30(12):1089-1096.
28. Flynn JM, Byrd JC: Campath-1H monoclonal antibody therapy. Curr Opin Oncol 2000, 12(6):574-581. (Pubitemid 32039657)
29. Nagler A, Condiotti R, Lubina A, Deutsch VR: Enhancement of megakaryocytopoiesis by Campath-1G-treated natural killer cells. Bone Marrow Transplant 1997, 20(7):525-531. (Pubitemid 27464559)
30. Hess DA, Meyerrose TE, Wirthlin L, Craft TP, Herrbrich PE, Creer MH, Nolta JA: Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004, 104(6):1648-1655. (Pubitemid 39202270)
31. Pearce DJ, Taussig D, Simpson C, Allen K, Rohatiner AZ, Lister TA, Bonnet D: Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 2005, 23(6):752-760. (Pubitemid 40791790)
32. Storms RW, Trujillo AP, Springer JB, Shah L, Colvin OM, Ludeman SM, Smith C: Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA 1999, 96(16):9118-9123. (Pubitemid 29374717)
33. McNiece IK, Almeida-Porada G, Shpall EJ, Zanjani E: Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol 2002, 30(6):612-616. (Pubitemid 34626658)
34. Hamood M, Corazza F, Bujan-Boza W, Sariban E, Fondu P: Natural killer (NK) cells inhibit human umbilical cord blood erythropoiesis. Exp Hematol 1995, 23(11):1187-1191.
35. Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E: Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000, 342(25):1846-1854. (Pubitemid 30419048)
36. Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y, Yamada T, Uchimaru K, Tojo A, Shirafuji N, Kodo H, Tani K, Takahashi T, Yamaguchi T, Asano S: Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004, 104(12):3813-3820. (Pubitemid 39564462)
37. Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M, Fukuno K, Uchiyama M, Takasugi K, Iseki T, Tojo A, Yamaguchi T, Asano S: Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 2007, 109(3):1322-1330. (Pubitemid 46220686)
38. Shah AJ, Kapoor N, Crooks GM, Weinberg KI, Azim HA, Killen R, Kuo L, Rushing T, Kohn DB, Parkman R: The effects of Campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants. Biol Blood Marrow Transplant 2007, 13(5):584-593. (Pubitemid 46585929)
39. Tse W, Bunting KD, Laughlin MJ: New insights into cord blood stem cell transplantation. Curr Opin Hematol 2008, 15(4):279-284.
40. Jones RJ, Barber JP, Vala MS, Collector MI, Kaufmann SH, Ludeman SM, Colvin OM, Hilton J: Assessment of aldehyde dehydrogenase in viable cells. Blood 1995, 85(10):2742-2746.